Shape as an Independent Design Parameter for Blood–Brain Barrier Crossing: Anisotropic Nanoparticles in Neurodegenerative Diseases
Background: Neurodegenerative diseases (NDDs) impose a growing burden, yet effective therapy remains limited because the blood–brain barrier (BBB) restricts CNS drug delivery. Existing reviews treat particle geometry as secondary to composition, size, and surface functionalization. Objectives: This review examines shap...